Antiangiogenic tumor therapy

被引:10
作者
Davis, DW [1 ]
McConkey, DJ [1 ]
Zhang, W [1 ]
Herbst, RS [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
D O I
10.2144/03345dd01
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1048 / +
页数:9
相关论文
共 99 条
[61]  
Liotta L A, 1990, Semin Cancer Biol, V1, P99
[62]   Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth [J].
Lyden, D ;
Hattori, K ;
Dias, S ;
Costa, C ;
Blaikie, P ;
Butros, L ;
Chadburn, A ;
Heissig, B ;
Marks, W ;
Witte, L ;
Wu, Y ;
Hicklin, D ;
Zhu, ZP ;
Hackett, NR ;
Crystal, RG ;
Moore, MAS ;
Hajjar, KA ;
Manova, K ;
Benezra, R ;
Rafii, S .
NATURE MEDICINE, 2001, 7 (11) :1194-1201
[63]   Resting and activated endothelial cells are increased in the peripheral blood of cancer patients [J].
Mancuso, P ;
Burlini, A ;
Pruneri, G ;
Goldhirsch, A ;
Martinelli, G ;
Bertolini, F .
BLOOD, 2001, 97 (11) :3658-3661
[64]   HIGH-AFFINITY VEGF BINDING AND DEVELOPMENTAL EXPRESSION SUGGEST FLK-1 AS A MAJOR REGULATOR OF VASCULOGENESIS AND ANGIOGENESIS [J].
MILLAUER, B ;
WIZIGMANNVOOS, S ;
SCHNURCH, H ;
MARTINEZ, R ;
MOLLER, NPH ;
RISAU, W ;
ULLRICH, A .
CELL, 1993, 72 (06) :835-846
[65]   GLIOBLASTOMA GROWTH INHIBITED IN-VIVO BY A DOMINANT-NEGATIVE FLK-1 MUTANT [J].
MILLAUER, B ;
SHAWVER, LK ;
PLATE, KH ;
RISAU, W ;
ULLRICH, A .
NATURE, 1994, 367 (6463) :576-579
[66]  
Mundhenke C, 2001, CLIN CANCER RES, V7, P3366
[67]   Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer [J].
Murray, GI ;
Duncan, ME ;
ONeil, P ;
Melvin, WT ;
Fothergill, JE .
NATURE MEDICINE, 1996, 2 (04) :461-462
[68]  
O'Reilly MS, 2002, CANCER J, V8, pS89
[69]   Angiostatin induces and sustains dormancy of human primary tumors in mice [J].
OReilly, MS ;
Holmgren, L ;
Chen, C ;
Folkman, J .
NATURE MEDICINE, 1996, 2 (06) :689-692
[70]  
*OSI PHARM, 2001, EXPERT REV ANTICANC, V1, P4